KMB · Kimberly-Clark Corporation

Kimberly-Clark's Q1 2026 results demonstrated resilience amid geopolitical and macroeconomic uncertainty, with net sales reaching $4.2 billion, up 2.7% reported and 2.5% organically, fueled by 3.0% volume-plus-mix growth from consumer-inspired innovations and strong execution, despite a 0.5% pricing decline to drive trial and value. Gross margin contracted to 36.8% GAAP (37.9% adjusted, down 60 bps), as productivity savings were offset by unfavorable pricing net of inflation and supply chain investments tied to new product launches and portfolio enhancements. Adjusted operating profit rose 3.7% to $732 million, supported by productivity, lower marketing/research/general expenses, and favorable currency. North America sales dipped 0.6% due to private label diaper exit but showed 1.8% organic growth; IPC surged 9.1% with 4.0% organic from volume and mix gains. CEO Mike Hsu highlighted the 'Powering Care' growth engine building share momentum and readiness for the Kenvue acquisition, with a robust Q2 innovation pipeline. Cash from operations jumped to $745 million, enabling $418 million in dividends amid $7.1 billion debt. The reaffirmed 2026 outlook signals confidence: organic sales tracking category growth, mid-to-high single-digit adjusted op profit expansion, double-digit adjusted continuing EPS growth on constant currency, with adjusted tax at 23%, tempered by IFP divestiture impacts mid-year.